MIMM 387 — The Business of Science

Name: MIMM 387 — The Business of Science
Rating: 2.9 (589 reviews)

The ability to select and manipulate genetic material has led to unprecedented interest in the industrial applications of procaryotic and eucaryotic cells. Beginning in the 1970s the introduction of and subsequent refinements to recombinant DNA technology and hybridoma technology transformed the horizons of the biopharmaceutical world. This course will highlight the important events that link basic research to clinical/commercial application of new drugs and chemicals.

Rating: 2.90 out of 5 from 589 student reviews
Difficulty: 3.10 out of 5
Credits: 3
Faculty: Faculty of Science
Department: Microbiology & Immunology
Prerequisite: At least one 200-level course in a biological or biomedical discipline or permission of instructor